Indication
Treatment of essential hypertension. Treatment of renal disease in patients with hypertension and type-2 diabetes mellitus as part of an antihypertensive medicinal-product regimen.
Loading your page…
Loading your page…
Hypertension
Marketing Authorisation Holder: Sanofi Winthrop Industrie
EMA Authorisation: 26/08/1997
INN: irbesartan
AI Drug & Interaction Analysis
Free account required
Ask Osler about Aprovel: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.